These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 2022737)

  • 1. Barrier function regulates epidermal DNA synthesis.
    Proksch E; Feingold KR; Man MQ; Elias PM
    J Clin Invest; 1991 May; 87(5):1668-73. PubMed ID: 2022737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Barrier function regulates epidermal lipid and DNA synthesis.
    Proksch E; Holleran WM; Menon GK; Elias PM; Feingold KR
    Br J Dermatol; 1993 May; 128(5):473-82. PubMed ID: 8504036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The lovastatin-treated rodent: a new model of barrier disruption and epidermal hyperplasia.
    Feingold KR; Man MQ; Proksch E; Menon GK; Brown BE; Elias PM
    J Invest Dermatol; 1991 Feb; 96(2):201-9. PubMed ID: 1991980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutaneous barrier perturbation stimulates cytokine production in the epidermis of mice.
    Wood LC; Jackson SM; Elias PM; Grunfeld C; Feingold KR
    J Clin Invest; 1992 Aug; 90(2):482-7. PubMed ID: 1644919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sphingolipids are required for mammalian epidermal barrier function. Inhibition of sphingolipid synthesis delays barrier recovery after acute perturbation.
    Holleran WM; Man MQ; Gao WN; Menon GK; Elias PM; Feingold KR
    J Clin Invest; 1991 Oct; 88(4):1338-45. PubMed ID: 1918384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Regulation of the epidermal permeability barrier by lipids and hyperproliferation].
    Proksch E
    Hautarzt; 1992 Jun; 43(6):331-8. PubMed ID: 1628964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pseudo-acylceramide with linoleic acid produces selective recovery of diminished cutaneous barrier function in essential fatty acid-deficient rats and has an inhibitory effect on epidermal hyperplasia.
    Imokawa G; Yada Y; Higuchi K; Okuda M; Ohashi Y; Kawamata A
    J Clin Invest; 1994 Jul; 94(1):89-96. PubMed ID: 8040295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The morphologic changes in lamellar bodies and intercorneocyte lipids after tape stripping and occlusion with a water vapor-impermeable membrane.
    Jiang S; Koo SW; Lee SH
    Arch Dermatol Res; 1998 Mar; 290(3):145-51. PubMed ID: 9558490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Permeability barrier disruption coordinately regulates mRNA levels for key enzymes of cholesterol, fatty acid, and ceramide synthesis in the epidermis.
    Harris IR; Farrell AM; Grunfeld C; Holleran WM; Elias PM; Feingold KR
    J Invest Dermatol; 1997 Dec; 109(6):783-7. PubMed ID: 9406821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term glucocorticoid treatment compromises both permeability barrier homeostasis and stratum corneum integrity: inhibition of epidermal lipid synthesis accounts for functional abnormalities.
    Kao JS; Fluhr JW; Man MQ; Fowler AJ; Hachem JP; Crumrine D; Ahn SK; Brown BE; Elias PM; Feingold KR
    J Invest Dermatol; 2003 Mar; 120(3):456-64. PubMed ID: 12603860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrity of the permeability barrier is crucial for maintenance of the epidermal calcium gradient.
    Menon GK; Elias PM; Feingold KR
    Br J Dermatol; 1994 Feb; 130(2):139-47. PubMed ID: 8123567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cutaneous permeability barrier disruption increases fatty acid synthetic enzyme activity in the epidermis of hairless mice.
    Ottey KA; Wood LC; Grunfeld C; Elias PM; Feingold KR
    J Invest Dermatol; 1995 Mar; 104(3):401-4. PubMed ID: 7861009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transepidermal water loss: the signal for recovery of barrier structure and function.
    Grubauer G; Elias PM; Feingold KR
    J Lipid Res; 1989 Mar; 30(3):323-33. PubMed ID: 2723540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship of epidermal lipogenesis to cutaneous barrier function.
    Grubauer G; Feingold KR; Elias PM
    J Lipid Res; 1987 Jun; 28(6):746-52. PubMed ID: 3611976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of epidermal keratins and the cornified envelope protein involucrin is influenced by permeability barrier disruption.
    Ekanayake-Mudiyanselage S; Aschauer H; Schmook FP; Jensen JM; Meingassner JG; Proksch E
    J Invest Dermatol; 1998 Sep; 111(3):517-23. PubMed ID: 9740250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. trans-4-(Aminomethyl)cyclohexane carboxylic acid (T-AMCHA), an anti-fibrinolytic agent, accelerates barrier recovery and prevents the epidermal hyperplasia induced by epidermal injury in hairless mice and humans.
    Denda M; Kitamura K; Elias PM; Feingold KR
    J Invest Dermatol; 1997 Jul; 109(1):84-90. PubMed ID: 9204960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional and structural changes of the epidermal barrier induced by various types of insults in hairless mice.
    Ahn SK; Jiang SJ; Hwang SM; Choi EH; Lee JS; Lee SH
    Arch Dermatol Res; 2001 Jun; 293(6):308-18. PubMed ID: 11480591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Localization of epidermal sphingolipid synthesis and serine palmitoyl transferase activity: alterations imposed by permeability barrier requirements.
    Holleran WM; Gao WN; Feingold KR; Elias PM
    Arch Dermatol Res; 1995; 287(3-4):254-8. PubMed ID: 7598529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Omega-hydroxyceramides are required for corneocyte lipid envelope (CLE) formation and normal epidermal permeability barrier function.
    Behne M; Uchida Y; Seki T; de Montellano PO; Elias PM; Holleran WM
    J Invest Dermatol; 2000 Jan; 114(1):185-92. PubMed ID: 10620136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The changes of epidermal calcium gradient and transitional cells after prolonged occlusion following tape stripping in the murine epidermis.
    Ahn SK; Hwang SM; Jiang SJ; Choi EH; Lee SH
    J Invest Dermatol; 1999 Aug; 113(2):189-95. PubMed ID: 10469302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.